Skip to content
Dr. Grey AI

Condition

Acute Respiratory Infection (ARI)

Acute respiratory infections, such as colds, flu and bronchitis, are mostly viral infections of the nose, throat and airways, where the immune response brings on inflammation, extra mucus and cough. The evidence is strongest for zinc, where a large review of trials found a lower risk of these infections, and moderate for Pelargonium sidoides, where bronchitis symptoms eased. The Pelargonium studies were small, though, and vitamin C showed no clear difference in infection risk.

Sources: PMID 34728441; PMID 18222667

Supplements studied
11
Medicines and peptides
1
Graded outcomes
12
Trials
7
People studied
26,573

Evidence by supplement

  • Strong
  • Moderate
  • Limited
  • Very limited

11 supplements

Zinc: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Acute Respiratory Tract Infection Risk

Moderate Improvement

Improves (the measure goes down)Moderate effect1 study5,446 people
Acute Respiratory Tract Infection SymptomsImproves (the measure goes down)5,446 people
Common Cold RiskChanges; see studies5,446 people
Umckaloabo: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Bronchitis Symptoms

Moderate Improvement

Improves (the measure goes down)Moderate effect4 studies341 people
Common Cold SymptomsImproves (the measure goes down)1 study1,771 people

Studies that measured common cold symptoms

Nasal CongestionImproves (the measure goes up)1 study1,771 people
Upper Respiratory Tract Infection SymptomsImproves (the measure goes down)1 study990 people

Studies that measured upper respiratory tract infection symptoms

Vitamin D

  • Asthma Symptoms: improves
  • Upper Respiratory Tract Infection Risk: changes; see studies
  • COPD Symptoms: improves
Vitamin D: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Asthma Symptoms

Small Improvement

Improves (the measure goes down)Small effect2 studies11,321 people
Upper Respiratory Tract Infection RiskChanges; see studies13 studies3,958 people
COPD SymptomsImproves (the measure goes down)11,321 people
Lower Respiratory Tract Infection RiskChanges; see studies10,993 people

Rhamnogalacturonan I

  • Cold Symptom Severity: improves
Rhamnogalacturonan I: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Cold Symptom Severity

A single RCT (n=146) challenged healthy volunteers with rhinovirus-16 after 8 weeks of carrot-derived RG-I supplementation (0.3 or 1.5 g/day). cRG-I significantly reduced WURSS-21 symptom scores (p<0.001) and improved quality of life measures (p<0.01) compared to placebo, with 0.3 g/day showing the strongest effects.

Improves (the measure goes down)Moderate effect1 study146 people

Vitamin C

  • Upper Respiratory Tract Infection Risk
  • Upper Respiratory Tract Infection Symptoms: improves
Vitamin C: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Upper Respiratory Tract Infection Risk

No effect

NoneNo effect5 studies1,332 people
Upper Respiratory Tract Infection SymptomsImproves (the measure goes down)24 studies666 people

Studies that measured upper respiratory tract infection symptoms

and 21 more on the Vitamin C page

Mitoquinone mesylate

  • SARS-CoV-2 Infection Risk: improves
Mitoquinone mesylate: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
SARS-CoV-2 Infection Risk

An exploratory open-label non-randomized pilot trial (Chen et al., 2024) in 80 individuals with high-risk SARS-CoV-2 exposure found 30% infection rate with MitoQ (20 mg/day for 14 days) vs. 75% in matched controls. Supported by preclinical data (Petcherski et al., 2022, preprint) showing nanomolar antiviral potency in cell and mouse models. Non-randomized design limits conclusions.

Improves (the measure goes down)Moderate effect4 studies80 people

Violet Flower

  • Respiratory Infection Symptoms: improves
Violet Flower: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Respiratory Infection Symptoms

A randomized double-blind controlled trial in 108 COVID-19 outpatients found that add-on violet syrup significantly improved cough (P=0.025), myalgia (P=0.036), and headache (P=0.037) over 7 days compared to standard care alone.

Improves (the measure goes down)Small effect2 studies108 people

Studies that measured respiratory infection symptoms

Yeast Mannan

  • Infection Resistance: improves
Yeast Mannan: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Infection Resistance

In European sea bass, MOS feeding improved survival following pathogen challenge. A broiler chicken study demonstrated improved responses to Salmonella typhimurium challenge with dietary yeast cell wall components including MOS. Evidence is limited to animal models.

Improves (the measure goes up)Small effect2 studies

Echinacea

  • Sleep Quality
  • Upper Respiratory Tract Infection Risk: changes; see studies
Echinacea: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Sleep Quality

No effect

NoneNo effect143 people
Upper Respiratory Tract Infection RiskChanges; see studies10 studies143 people

Slippery Elm

  • Sore Throat Symptom Relief: changes; see studies
Slippery Elm: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Sore Throat Symptom Relief

No controlled clinical trials specifically evaluate slippery elm for sore throat. The mucilage content provides a plausible mechanical coating/soothing mechanism, and slippery elm is a common ingredient in commercial throat lozenges, but direct clinical evidence is absent. Efficacy is inferred from traditional use and the well-characterized demulcent properties of plant mucilage.

Changes; see studiesSmall effect

Elderberry

  • Upper Respiratory Tract Infection Symptoms: improves
Elderberry: outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Upper Respiratory Tract Infection SymptomsImproves (the measure goes down)3 studies87 people

Prescription medicines and peptides studied, for context

These are not supplements. Most need a prescription, and some are research compounds with no approved use. They are listed so the supplement evidence above can be read against them.

1 medicine or peptide

Telavancin (Vibativ)

  • Hospital-Acquired Pneumonia Efficacy
  • Mortality in Renal Impairment: worsens
Telavancin (Vibativ): outcomes studied for Acute Respiratory Infection (ARI)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Hospital-Acquired Pneumonia Efficacy

ATTAIN-1 & ATTAIN-2 Phase 3: Clinical cure rates comparable to vancomycin for S. aureus HABP/VABP. FDA-approved June 2013 but indicated only when alternative treatments not suitable due to safety concerns.

NoneNo effect8 studies
Mortality in Renal Impairment

SAFETY CONCERN: FDA black box warning for increased mortality in patients with CrCl <50 mL/min in HABP/VABP trials. Telavancin should only be used when alternatives not suitable. Risk-benefit assessment required.

Worsens (the measure goes up)Moderate effect6 studies

Key findings

  • Acute Respiratory Tract Infection RiskZincImproves (the measure goes down)
  • Bronchitis SymptomsUmckaloaboImproves (the measure goes down)
  • Asthma SymptomsVitamin DImproves (the measure goes down)

Safety notes in the studies

  • An exploratory open-label non-randomized pilot trial (Chen et al., 2024) in 80 individuals with high-risk SARS-CoV-2 exposure found 30% infection rate with MitoQ (20 mg/day for 14 days) vs.
  • SAFETY CONCERN: FDA black box warning for increased mortality in patients with CrCl <50 mL/min in HABP/VABP trials.
  • Risk-benefit assessment required.

The Acute Respiratory Infection (ARI) Treatment Support protocol

2 primary supplements · 7 supporting supplements

See the full protocol

Shop the evidence-backed picks

Fullscript collectionImmune support: evidence-graded picksOpen on Fullscript

Or shop one supplement

The supplements graded A or B for Acute Respiratory Infection (ARI). Each opens third-party tested products for that supplement.

  • Grade A
  • Grade B

We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure

Studies cited

2 studies from PubMed

  1. Effect of long-acting garlic tablets "allicor" on the incidence of acute respiratory viral infections in childrenTer Arkh · PMID 12718222
  2. Honey for acute cough in children - a systematic review.Eur J Pediatr · PMID 37355498